Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients
Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia
VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia
Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society



The Hematologist